Hosted on MSN

Essilorluxottica’s Innovative Lens Trial: A Potential Game-Changer for Juvenile Myopia

Essilorluxottica (OTC) ((ESLOY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Monthly Prescribing Reference

FDA Denies Sydnexis Approval for Pediatric Myopia Treatment

Submitted data were not enough to support the effectiveness of SYD-101 in children with myopia, according to the FDA. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) ...
ophthalmologytimes

FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment

The FDA issued a complete response letter for SYD-101, citing insufficient evidence of effectiveness despite achieving primary efficacy in the STAR trial. The STAR trial demonstrated significant ...
KWTX

Degrees of Science: Nearsightedness Study

(KWTX) -Over a third of American adults are nearsighted, and that number has gone up dramatically over the last few decades. There is a new national research study starting soon looking to delay the ...
IEEE

Research on Knowledge Framework and Classification of Traditional Chinese Medicine Diagnosis and Treatment for Myopia

Abstract: Objective To keep up with the progress of treatment for myopia in traditional Chinese medicine (TCM) through literature research, so as to determine data source of TCM diagnosis and ...